Articles with "dermatomyositis patients" as a keyword



Photo from wikipedia

Characteristics of hospitalized dermatomyositis patients with underlying malignancy: a nationally representative retrospective cohort study

Sign Up to like & get
recommendations!
Published in 2020 at "Archives of Dermatological Research"

DOI: 10.1007/s00403-020-02127-5

Abstract: Little is known regarding characteristics of hospitalized dermatomyositis (DM) patients. Understanding the unique characteristics of hospitalized DM patients with underlying malignancy is important in guiding development of specific work-up and treatment algorithms. We aim to… read more here.

Keywords: dermatomyositis patients; hospitalized dermatomyositis; underlying malignancy; malignancy ... See more keywords
Photo by charlesdeluvio from unsplash

Compound sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5.

Sign Up to like & get
recommendations!
Published in 2023 at "Rheumatology"

DOI: 10.1093/rheumatology/kead034

Abstract: OBJECTIVE Mortality of dermatomyositis patients positive with anti-melanoma differentiation-related gene 5 antibody (anti-MDA5-DM) is alarming, especially during the first several months. Infection is an important cause of early death. As there are no reports regarding… read more here.

Keywords: anti mda5; incidence; smz; patients positive ... See more keywords

Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reports

Sign Up to like & get
recommendations!
Published in 2022 at "Medicine"

DOI: 10.1097/md.0000000000030634

Abstract: Rationale: In December 2019, a new epidemic of coronavirus disease 2019 (COVID-19) appeared in Wuhan, Hubei Province, and spread rapidly to other parts of China and worldwide. Although established methods exist for the diagnosis and… read more here.

Keywords: case reports; patient; case; management dermatomyositis ... See more keywords
Photo by nate_dumlao from unsplash

Characteristics of anti-transcriptional intermediary factor 1 gamma autoantibody-positive dermatomyositis patients in Singapore.

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of the Academy of Medicine, Singapore"

DOI: 10.47102/annals-acadmedsg.2022278

Abstract: INTRODUCTION This study aimed to determine the clinical profile and outcome of anti-transcriptional intermediary factor 1 gamma autoantibody (anti-TIF1-γ Ab)-positive dermatomyositis patients and propose cancer screening programmes based on regional cancer trends. METHOD Data on… read more here.

Keywords: tif1 positive; anti transcriptional; positive dermatomyositis; dermatomyositis patients ... See more keywords